PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED

Tetrahydroquinoline Compounds As Antitumor Agents

NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS

METAL IRIDIUM COMPLEX AND USE THEREOF

METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP

SYNTHESIS OF MAVORIXAFOR AND INTERMEDIATES THEREOF

Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the Same

ABIETANES AND METHODS OF MAKING AND USING THE SAME

ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

ANTIDEGRADANT COMPOUNDS AND USES THEREOF

SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

THERAPEUTIC COMPOUNDS

ISOQUINOLINE AND PYRIDINE BASED CXCR4 ANTAGONISTS

SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS

Abietanes and methods of making and using the same

TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF

INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF

PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-DIOL

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER

DIHYDROQUINAZOLINONES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

NAMPT MODULATORS

ADDUCT COMPRISING AT LEAST A TRANSITION METAL AND AN ADDUCT OF A CARBON ALLOTROP AND A PYRROLIC COMPOUND

DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES

Tetrahydroquinoline derivatives as P2X7 receptor antagonists

RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF

TEAD INHIBITORS AND USES THEREOF

TRNA SYNTHETASE INHIBITORS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Small molecule antiviral drug treatment for human papillomavirus infections

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

COMPOUNDS AS MODULATORS OF TLR2 SIGNALING

ORGANIC COMPOUND AND APPLICATION THEREOF

Dihydroquinoline Photochromic Compounds

Nitrogen-containing compound, electronic element and electronic device

NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME

CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF

Covalent inhibitors of equine encephalitis virus

Organic compound, organic electroluminescent device and electronic apparatus

Compound, organic optoelectronic diode, and display device

Small molecule antiviral drug treatment for human papillomavirus infections

Quinoline-based proteasome inhibitors and uses thereof

Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diol

COMPOUNDS THAT CAN BE USED FOR PRODUCING AN ORGANIC ELECTRONIC DEVICE

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

Compounds and compositions for treating conditions associated with NLRP activity

Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents

Organic compound and organic light-emitting element

Tetrahydroquinoline derivatives as P2X7 receptor antagonists

TRNA synthetase inhibitors

Fused polycyclic dimers

Organic Material for an Electronic Optoelectronic Device and Electronic Device Comprising the Organic Material

Compounds as modulators of TLR2 signaling

LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM

Tetrahydroquinoline derivatives as P2X7 receptor antagonists

Modulators of integrated stress response pathway

PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF

Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF

Organic electroluminescent materials and devices

COMPOUNDS AND METHODS FOR TREATING CANCER

Catalyst-free and redox-neutral innate trifluoromethylation and alkylation of (hetero)aromatics enabled by light

Remote heteroaryl alkenylation with catalytic bifunctional template

Organic compound, organic light-emitting element, display apparatus, image pickup apparatus, electronic device, and moving object

Processes for the preparation of heterocyclic scaffolds from alpha enaminones

Green preparation method for quinoline compounds

Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

Quinoline alkenes as cytoprotective agents

NITROGEN CONTAINING BICYCLIC DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS

Process for the manufacture of 6-alkynyl-pyridine derivatives

Glucosylceramide synthase inhibitors for the treatment of diseases

Organic photoelectric functional material, method for preparing the same, use of the same, organic electronic assembly, and light-emitting device

Arthropod repellent chemicals

Direct C—H amination and aza-annulation

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

SYNTHETIC RETINOIDS FOR USE IN RAR MEDIATED CONDITIONS

NANO-TO-NANO FE/PPM Pd CATALYSIS OF CROSS-COUPLING REACTIONS IN WATER

Low system memory detection

Spiroketal-based C2-symmetric scaffold for asymmetric catalysis

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

Immunoregulatory agents

Heterocyclic compounds

Organic electroluminescent materials and devices

Sulfonylaminobenzamide compounds as anthelmintics

Corrosion inhibition

Quinoline-based proteasome inhibitors and uses thereof

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

Organic molecules for use in optoelectronic devices

Compound and organic electronic device comprising same

ORGANIC LIGHT EMITTING DEVICE WITH THERMALLY ACTIVATED DELAYED FLUORESCENT LIGHT EMITTING MATERIAL

Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines

Method for producing aromatic compound

Cyclic vinylogous amides as bromodomain inhibitors

Organic electroluminescent materials and devices

Boron-dipyrrin complex and medicament containing the same

Organic molecules for use in optoelectronic devices

N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

Enamine compounds for absorbance of electromagnetic energy

BLUE FLUORESCENT EMITTERS

Spiro-type compound and organic light emitting element comprising same

ANTHROPOD REPELLENT CHEMICALS

Chelation directed C—H activation reactions catalyzed by solid-supported palladium(II) catalysts

Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis

Nano-to-nano Fe/ppm Pd catalysis of cross-coupling reactions in water

Composite preparation, containing novel 3-(4--(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases

Benzenesulfonyl-asymmetric ureas and medical uses thereof

Sulfonylaminobenzamide compounds as anthelmintics

Fluorescent synthetic retinoids

Bimesogenic compounds and mesogenic media

Mixed metal double salt ionic liquids with tunable acidity

Immunoregulatory agents

Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof

Cure accelerators for anaerobic curable compositions

Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto

Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method

Organic electroluminescent element, compound and material for organic electroluminescent element capable of being used therefor, light emitting device, display device, and illumination device, each using the element

Method for manufacturing optically active compound

Method for producing optically active compound, and novel metal-diamine complex

Nano-to-nano Fe/ppm Pd catalysis of cross-coupling reactions in water

N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation

Fused bicyclic heteroaromatic derivatives as modulators of TNF activity

Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67

Arylquinoline and analog compounds and use thereof to treat cancer

ANTHROPOD REPELLENT CHEMICALS

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

FLUOROGENIC PROTECTING GROUP

Onium salt compound, resist composition, and pattern forming process

Heterocyclic compounds

Process for forming a primary, a secondary or a tertiary amine via a direct amination reaction

Glucosylceramide synthase inhibitors for the treatment of diseases

IDO inhibitors

Cyclic vinylogous amides as bromodomain inhibitors

Immunoregulatory agents

Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban

Histone deacetylase inhibitors and compositions and methods of use thereof

Fused polycyclic compound and organic light emitting element including the same

3-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for preventing and treating metabolic disease including same as effective ingredient

Inhibiting neurotransmitter reuptake

Compound and organic light-emitting device including the same

Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4

ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE

Method for producing purified amine compound

Indeno[1,2-b]phenanthrene compound and organic light emitting element including the same

Quinoline derivatives useful as CB-1 inverse agonists

Urea and amide derivatives of aminoalkylpiperazines and use thereof

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

Therapeutic compounds and compositions

Diamine compound and metal complexes, and method for producing optically active compounds

Compounds and methods for skin repair

Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method

Organic electroluminescent materials and devices

Methods and compositions for treatment of fibrosis

COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES

Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)

COMPOSITIONS AND METHODS FOR THE TREATMENT AND ANALYSIS OF NEUROLOGICAL DISORDERS

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1

Method for producing optically active tetrahydroquinolines

INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM

2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists

Heterobicyclic sphingosine 1-phosphate analogs

ANTI-NEURODEGENERATIVE DISEASE AGENT

-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors

Palladium catalyst, method for its preparation and its use

Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Solution-processable electron-transport materials and related organic optoelectronic devices

Palladium catalyst, method for its preparation and its use

Heterocyclic compounds suitable for the treatment of dyslipidemia

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

Compounds for modulating RNA binding proteins and uses therefor

2-quinolinyl-acetic acid derivatives as HIV antiviral compounds

IRIDIUM COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND

Curing agents

Organic compound and organic light-emitting device including the same

Organic compound and organic light emitting device having the same

-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors

Solid acid catalyst and method for preparing and using the same

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

Alkynyl derivatives as modulators of metabotropic glutamate receptors

Substituted phenoxypropylcycloamine derivatives as histamine-3 (H) receptor ligands

GLYCINE B ANTAGONISTS

Ion channel modulators and methods of use

C-linked hydroxamic acid derivatives useful as antibacterial agents

Therapeutic compounds and compositions

PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND

N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation

Cyclopamine lactam analogs and methods of use thereof

Cycloalkene derivatives and organic electronic devices using the same

ANTI-NEURODEGENERATIVE DISEASE AGENT

S1P receptors modulators

Cyclopamine lactam analogs and methods of use thereof

MODULATION OF ANXIETY THROUGH BLOCKADE OF ANANDAMIDE HYDROLYSIS

Acetanilide sphingosine-1-phosphate receptor antagonists

Solid supported gold nanoparticles, methods of use thereof, and methods for making same

CYCLOHEXYLAMINE DERIVATIVE CONTAINING PHENYL GROUP, AND THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY CENTRAL NERVOUS SYSTEM DISORDERS

Indenopyrene compound and organic light-emitting device using the compound

Imaging agents for detecting neurological disorders

Photocleavable Linker Methods and Compositions

SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

Solid acid catalyst and method for preparing and using the same

Anthracene derivative and an organic electronic device using the same

Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Compounds for modulating RNA binding proteins and uses therefor

Transition metal complex and process for producing conjugated aromatic compound using the transition metal complex

CHARGE CONTROL AGENT AND RELATED ART

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof

METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND

ANALGESIC THAT BINDS FILAMIN A

Imaging agents for detecting neurological disorders

1H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS

Modified malonate derivatives

Cyclic amine compound

Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production

Novel organic electroluminescent compounds and organic electroluminescent device using the same

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

Novel organic electroluminescent compounds and organic electroluminescent device using the same

Male contraceptive

Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof

Photocleavable linker methods and compositions

NON-IMIDAZOLE ARYLOXYALKYLAMINES

Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same

Hindered cyclic polyamines and their salts for acid gas scrubbing process

Method of enzymatic optical resolution of racemic 4-hydroxy-1,2,3,4-tetrahydroquinoline

Substituted amides

MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS

Substituted N-bicyclicalkyl bicycliccarboxyamide compounds

Novel organic electroluminescent compounds and organic electroluminescent device using the same

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS

Alkynyl derivatives as modulators of metatropic glutamate receptors

Amine linked modulators of γ-secretase

Method of making and administering quinoline derivatives as anti-cancer agents

Modulation of anxiety through blockade of anandamide hydrolysis

Compound and organic light emitting device

NON-IMIDAZOLE ARYLOXYALKYLAMINES

Novel compounds and a novel process for their preparation

Ion channel modulators and methods of use

Cyclopamine lactam analogs and methods of use thereof

Benzo(GHI)fluoranthene derivative and organic light emitting device using the same

Aminophenylpropanoic acid derivative

Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film

Substituted pyridyoxy amides

Phenylalkynes

Phenylalkynes

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

N-Acylated lipophilic amino acid derivatives

THERAPEUTIC COMPOUNDS

Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors

Novel Heterocyclic Compounds

Novel Compounds and Compositions as Cathepsin Inhibitors

Alkoxyphenylpropanoic acid derivatives

Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them

Phenylalkynes

Aniline derivatives

Synthesis of enantiomerically pure amino-substituted fused bicyclic rings

Cept inhibitors and metabolites thereof

Phenylalkynes

Non-imidazole aryloxyalkylamines

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

Substituted propargylamines

Histamine h3 receptor antagonists, preparation and therapeutic uses

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

Amide derivatives

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

Biaryloxymethylarenecarboxylic acids as glycogen synthase activators

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound

Compounds for the treatment of inflammatory disorders

Substituted aryl thioureas and related compounds; inhibitors of viral replication

Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

Ammonium salts of inositol hexaphosphate, and uses thereof

8-(biaryl)quinoline PDE4 inhibitors

Substituted amides

Non-imidazole aryloxypiperidines

Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production

Synthesis of enantiomerically pure amino-substituted fused bicyclic rings

N-acylated lipophilic amino acid derivatives

Substituted arylthiourea derivatives useful as inhibitors of viral replication

Compounds and a novel process for their preparation

Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters

Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same

Catalytic reduction of aromatic ring in aqueous medium

Cereal-based charcoal binder